Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 4, 2009, Pages 758-762

  Kersh, Ellen N ^a   Luo, Wei ^a   Adams, Debra R ^a   Mitchell, James ^a   Garcia Lerma, J Gerardo ^a   Butera, Sal ^a   Folks, Tom ^a   Otten, Ron ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV; Immune function; Immune regulation

Indexed keywords

CD4 ANTIGEN; FINGOLIMOD; VIRUS DNA;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DOSE INCREASE; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MACACA; MALE; NONHUMAN; SIMIAN IMMUNODEFICIENCY VIRUS; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD; VIRUS VIRULENCE;

ANIMALS; DNA, VIRAL; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAVENTRICULAR; LYMPHOCYTE COUNT; LYMPHOCYTES; MACACA MULATTA; MALE; PROPYLENE GLYCOLS; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPHINGOSINE; VIRAL LOAD;

EID: 62549151797     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp008     Document Type: Article

References (8)

1. Premenko-Lanier M, Moseley NB, Pruett ST et al. Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection. Nature 2008; 454: 894-8.
2. Massberg S, von Andrian UH. Fingolimod and sphingosine-1- phosphate - modifiers of lymphocyte migration. New Engl J Med 2006; 355: 1088-91.
3. Wherry EJ, Barber DL, Kaech SM et al. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004; 101: 16004-9.
4. Day CL, Kaufmann DE, Kiepiela P et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443: 350-4.
5. SF162P3. J Virol 2001; 75: 1990-5.
6. Subbarao S, Otten RA, Ramos A et al. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis 2006; 194: 904-11.
7. Quesniaux V, Fullard L, Arendse H et al. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons. Transpl Immunol 1999; 7: 149-57.
8. Kersh EN, Luo W, Adams DR et al. Short communication: No evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS Res Hum Retroviruses 2008; 24: 543-6.